Aristo Bio-Tech and Lifescience Limited
Aristo Bio-Tech and Lifescience Limited, headquartered in India, is a prominent player in the biotechnology and life sciences sector. Founded in 2005, the company has established itself as a leader in the development and manufacturing of innovative biopharmaceuticals and healthcare solutions. With a strong operational presence across various regions in India, Aristo Bio-Tech focuses on delivering high-quality products that cater to the evolving needs of the healthcare industry. The company’s core offerings include a diverse range of biopharmaceuticals, including vaccines and therapeutic proteins, distinguished by their advanced formulation and efficacy. Aristo Bio-Tech's commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. With a reputation for excellence and a dedication to improving patient outcomes, Aristo Bio-Tech continues to make strides in the life sciences landscape.
DitchCarbon Score
How does Aristo Bio-Tech and Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aristo Bio-Tech and Lifescience Limited's score of 8 is lower than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aristo Bio-Tech and Lifescience Limited's reported carbon emissions
In 2023, Aristo Bio-Tech and Lifescience Limited reported a total Scope 1 and Scope 2 emission intensity of approximately 3,380 kg CO2e per tonne of revenue. This figure reflects their emissions relative to their revenue of about USD 26,528,675. In comparison, the 2022 emission intensity was slightly lower at approximately 3,370 kg CO2e per tonne of revenue, with a revenue of about USD 21,842,658. Currently, there are no specific reduction targets or climate pledges disclosed by Aristo Bio-Tech and Lifescience Limited. The company has not provided detailed data on Scope 1, Scope 2, or Scope 3 emissions, nor have they outlined any significant initiatives aimed at reducing their carbon footprint. As such, their climate commitments remain vague within the industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aristo Bio-Tech and Lifescience Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
